Circulating tumor cells shed from breast carcinoma, are a heterogeneous population including EpCAM-positive cells and cells with mesenchymal phenotype (EMT), which are studied for the analysis of the therapeutic response to different chemotherapeutic regimens [31]. Here, EPCAM is linked to neoplasm.